iShares MSCI China ETF vs Medline Inc. Class A Common Stock — how do they compare? iShares MSCI China ETF trades at $52.55 (market cap $5.94B), while Medline Inc. Class A Common Stock trades at $36.26 (market cap $31.36B). The key difference: Medline Inc. Class A Common Stock is far larger — about 5.3× iShares MSCI China ETF's market cap, and Medline Inc. Class A Common Stock is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI China ETF for 63 Days and Medline Inc. Class A Common Stock for 1 Days on average.
| MCHI | MDLN | |
|---|---|---|
Market Cap | $5.94B | $31.36B |
Volume | 1,575,471 | 10,191,251 |
Sector | Broad Market / Factor | Health |
52-Week High | $65.59 | $49.99 |
52-Week Low | $50.48 | $31.64 |
Typical Hold Time | 63 Days | 1 Days |
Enterprise Value | — | $41.32B |
Signals from Pluang's Aura AI — not financial advice
MCHI trades at $51.36, down 0.54% with bearish technical signals from moving averages. The ETF faces headwinds from China's economic challenges including industrial overcapacity and weak domestic consumption. Recent news highlights trade tensions ahead of U.S.-China talks, though corporate profits surged 26% in Q2. Technical indicators show oversold conditions with RSI at 25.44 suggesting potential for near-term bounce.
The outlook remains cautious given China's macroeconomic pressures and trade uncertainties. Investment opportunity exists in MCHI's significant discount to historical valuations versus U.S. indices. Key risks include potential export controls, protectionism threats, and China's reliance on infrastructure spending rather than broad stimulus to support growth.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →